A. Agrotis et al., VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION IN SHR AND WKY RATS - EVIDENCE FOR SPECIFIC DIFFERENCES IN GROWTH-INHIBITORY REGULATORY MECHANISMS, Clinical and experimental pharmacology and physiology, 20(5), 1993, pp. 327-330
1. This study examined and compared the actions of transforming growth
factor-beta1 (TGF-beta1), heparin, dexamethasone and interferon-gamma
on platelet-derived growth factor-BB (PDGF-BB)-stimulated proliferati
on of vascular smooth muscle cells (VSMC) from normotensive, Wistar-Ky
oto (WKY) rats and spontaneously hypertensive rats (SHR). 2. Heparin,
dexamethasone and interferon-gamma all inhibited VSMC proliferation st
imulated by PDGF-BB in both SHR and WKY rats. There was no difference
(P>0.05) in their inhibitory effects, which varied between 40 and 85%
for the different agents. 3. Similarly, TGF-beta1 inhibited PDGF-BB-st
imulated VSMC proliferation in WKY rats by approximately 50%. In contr
ast, TGF-beta1 potentiated growth factor action on cell proliferation
in the SHR by approximately 40%. 4. Specific TGF-beta1-stimulated regu
latory mechanisms involved in the inhibition of proliferation are abse
nt in SHR and this defect may contribute to the vascular hypertrophy w
hich is apparent in genetic hypertension.